Rights and permissions
About this article
Cite this article
Casemix funding and DRGs ignore quality and outcome issues. Pharmacoecon. Outcomes News 168, 5 (1998). https://doi.org/10.1007/BF03284908
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03284908